Sitemap

Company

Who We Are

• About Lilly

  • Key Facts

    • Position Statements

  • Milestones of Caring and Discovery Timeline

• Recognitions

Leadership

• Governance

• Executive Committee

  • David A. Ricks

  • Anat Ashkenazi

  • Eric Dozier

  • Anat Hakim

  • Edgardo Hernandez

  • Patrik Jonsson

  • Michael B. Mason

  • Johna L. Norton

  • Leigh Ann Pusey

  • Diogo Rau

  • Daniel M. Skovronsky, M.D., Ph.D.

  • Jacob Van Naarden

  • Alonzo Weems

  • Anne E. White

  • Ilya Yuffa

• Board of Directors

  • David A. Ricks

  • Ralph Alvarez

  • Katherine Baicker, Ph.D.

  • J. Erik Fyrwald

  • Jamere Jackson

  • Kimberly H. Johnson

  • William G. Kaelin Jr., M.D.

  • Juan R. Luciano

  • Marschall S. Runge, M.D., Ph.D.

  • Gabrielle Sulzberger

  • Jackson P. Tai

  • Karen Walker

Policies & Reports

• Public Policy

  • Payments to Health Care Professionals

  • Public Policy Engagement and Political Participation

• CEO Dave Ricks' Letter to Shareholders

  • Science

  • Business

  • Access and Affordability

  • Global Health

  • Community Engagement

  • Diversity and Inclusion

    • Our Diversity and Inclusion Progress Report

  • Environmental

  • Governance

• Annual Report and Proxy Statement

  • 2019 Integrated Summary Report

• Our Tax Principles

Powered by Purpose

• Powered by Purpose

Science

Discovery

• Clinical Development Pipeline

• Research & Scientific Discovery

  • Elixir Factor Podcast

  • 100 Years of Insulin

    • 100 Years of Insulin Timeline

  • Science Stories

• Principles of Medical Research

  • Research Ethics

  • Animal Care and Use

Disease Areas

• Alzheimer's

• Cancer

• Diabetes

• Immunology

• Obesity

• Pain

Clinical Research

• Clinical Trials

• Diversity in Clinical Trials

• Expanded Access

• CSR Synopses

Partners

• Collaborate With Us

• Scientific Areas of Interest

• Our Approach to Partnering

• Office of Alliance Management

• Lilly Research Award Program

Medicines

Safety

• Patient Safety

  • Our Commitment to Patient Safety

  • FDA's Role

• Medication Safety

  • Product Protection

• Manufacturing & Quality

  • Manufacturing for Better Lives

  • European Union Declarations

  • Product Cybersecurity Vulnerability Disclosure

Our Medicines

• Current Medicines

• Historic Medicines

• Suggestions for Patients

  • HCP Medical Information

Resources

• Lilly Diabetes Solution Center

  • The Insulin Affordability Conversation

  • Insulin Access and Affordability

• Lilly Insulin State Patient Assistance Programs

  • Lilly Colorado Insulin State Patient Assistance Program

  • Lilly Minnesota Insulin Safety Net Program

• Lilly Oncology Support Center

• Lilly Pricing Information

• The Lilly Answers Center

• Lilly Cares Foundation

Impact

Impact

• Our Impact

• Lilly Foundation

• Lilly Grant Office

Impact Areas

• Increase Access to Medicines

• Improve Lives and Communities

  • Caring Stories

• Empower a Diverse Workforce

  • Women at Lilly

  • Diversity and Inclusion Stories

• Minimizing Our Environmental Impact

• Operate Ethically and Responsibly

  • Ethical Conduct for Financial Management

Transparency

• ESG Reports

News

Stories

• Caring

• Science

• Policy

• All Stories

Press Releases

• Recent

• Archives

Media

• All News

• Media Kits

  • Neutralizing Antibodies for COVID-19

  • Baricitinib for COVID-19

  • Cyramza

  • Retevmo

  • Reyvow

• Media Contacts

• Lilly Corporate Social Media Guidelines

Footer

Diversity

Contact

• Designated Alternate Contacts for Reporting Concerns (for Countries That Limit Hotline Reporting)

Suppliers

• Prospective Suppliers

• Accounts Payable

  • Accounts Payable Privacy Statement

  • New and Existing Supplier Setup

  • Payments

  • Accounts Payable Resources

  • Lilly Supplier eConnect page

• Supplier Resources

  • Suppliers: Operating Responsibly

  • Pharmaceutical Marketer Price Disclosure Law: Vermont

• Supplier Diversity

Login

Terms of Use

Privacy Statement